You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bl-b01d1

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

Not yet recruiting
  • Small Cell Lung Cancer
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Jun 21, 2023

Cervical Cancer Trial in Beijing (BL-B01D1, SI-B003)

Not yet recruiting
  • Cervical Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Aug 16, 2023

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 17, 2023

Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2023

Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Urothelial Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 27, 2023

Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • BL-B01D1
  • Port Saint Lucie, Florida
  • +1 more
Aug 11, 2023

Gynecological Malignant Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)

Not yet recruiting
  • Gynecological Malignant Tumor
  • Solid Tumor
  • BL-B01D1
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Apr 9, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (BL-B01D1, capecitabine, gemcitabine)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • BL-B01D1
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 31, 2023

NSCLC Trial in Shanghai (BL-B01D1, Osimertinib Mesylate Tablets)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • BL-B01D1
  • Osimertinib Mesylate Tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
May 25, 2023

Urinary System Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)

Not yet recruiting
  • Urinary System Tumor
  • Solid Tumor
  • BL-B01D1
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Mar 26, 2023

Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 22, 2023

Locally Advanced or Metastatic Urinary Tumors, Other Solid Tumors Trial in Beijing (BL-B01D1)

Recruiting
  • Locally Advanced or Metastatic Urinary Tumors
  • Other Solid Tumors
  • BL-B01D1
  • Beijing, Beijing, China
  • +3 more
Jan 11, 2023

Breast Cancer, Solid Tumor Trial in Shanghai (BL-B01D1)

Recruiting
  • Breast Cancer
  • Solid Tumor
  • BL-B01D1
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Jul 20, 2022

NSCLC, Nasopharyngeal Carcinoma Trial in China (BL-B01D1, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Nasopharyngeal Carcinoma
  • Chongqing, Chongqing, China
  • +15 more
Jul 13, 2023

Gastrointestinal Tumor Trial in Beijing (BL-B01D1)

Recruiting
  • Gastrointestinal Tumor
  • BL-B01D1
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 21, 2022

Locally Advanced or Metastatic Solid Tumor Trial in Guanzhou (BL-B01D1)

Recruiting
  • Locally Advanced or Metastatic Solid Tumor
  • BL-B01D1
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jan 4, 2022